Structure Therapeutics (GPCR) Capital Expenditures (2022 - 2026)
Structure Therapeutics' Capital Expenditures came in at -$42,000 for Q2 2026, compared with $232,000 a year earlier.
Powered by 
Analysis
Structure Therapeutics (GPCR) Capital Expenditures (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Structure Therapeutics reported Capital Expenditures of $4.21 million, up 237.4% year-over-year; for FY2025, it was $3.61 million, up 180.2% from FY2024.
- Capital Expenditures carries a three-year compound annual growth rate of 185.7% (FY2022 to FY2025).
- Going back by year, Capital Expenditures was $1.29 million in FY2024 (-40.5%), $2.17 million in FY2023 and $155,000 in FY2022.
- The Q2 2026 figure represents the lowest quarterly Capital Expenditures since Q2 2022.
- Year-over-year, Capital Expenditures increased in three of the last six quarters, with growth averaging 56.5%.
- Business Quant data shows GPCR's Capital Expenditures at $1.18 million (Q1 2026), $1.5 million (Q4 2025) and $1.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Structure Therapeutics | 7.49 Bn | 7.49 Bn | - | -42,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42,000.00 |
| Mar 31, 2026 | 1.18 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 232,000.00 |
| Mar 31, 2025 | 314,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | 685,000.00 |
| Jun 30, 2024 | 427,000.00 |
| Mar 31, 2024 | 162,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 820,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 72,000.00 |
| Jun 30, 2022 | -53,000.00 |
| Mar 31, 2022 | 65,000.00 |
API Access
Structure Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GPCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "GPCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GPCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();